19:48:37 EDT Sun 13 Jun 2021
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save
Delta 9 Cannabis Inc
Symbol DN
Shares Issued 102,084,581
Close 2021-05-06 C$ 0.55
Recent Sedar Documents

Delta 9 expects Q1 2021 revenue of up to $13.25-million

2021-05-06 18:15 ET - News Release

Mr. John Arbuthnot reports

DELTA 9 PROVIDES GUIDANCE & TIMING FOR Q1 2021 RESULTS

Delta 9 Cannabis Inc. has provided guidance on select financial results for the first quarter of 2021 based on preliminary results.

The company anticipates revenue for the three-month period ending March 31, 2021, to be between $12.9-million and $13.25-million compared with:

  • $11.75-million for the first quarter of 2020;
  • $14.15-million for the fourth quarter of 2020.

The company anticipates direct cannabis production cost per gram of 60 cents and total cost per gram of 75 cents for the first quarter 2021, compared with 67 cents and 80 cents, respectively, for the fourth quarter of 2020.

The company anticipates total grams of cannabis produced of 2,178,181 for the first quarter of 2021, compared with 2,128,288 grams of cannabis for the fourth quarter 2020.

The company anticipates reporting total retail transactions processed of 210,138 for the first quarter of 2021, compared with 202,347 for the fourth quarter of 2020.

"Our Q1 2021 performance demonstrates another quarter of year-over-year growth," said John Arbuthnot, co-founder and chief executive officer of Delta 9. "This quarter we continue to add addition retail stores across Central Canada, expand our B2B business into the U.S. market place and find efficiencies to lower our wholesale production cost per gram. In Q1 we have seen a degree of seasonality and relative Canadian cannabis market weakness affecting our business and impacting sequential revenue growth; however, we remain bullish that the remainder of 2021 looks to be a promising year for Delta 9."

Delta 9 will provide investors with a full breakdown on its progress in these areas as part of its first quarter results, which will be released on May 17, 2021, before the market opens. This will be followed by a conference call the same morning, the details of which can be found at the end of this release.

The preliminary estimated financial results and other data for the three-month period ended March 31, 2021, set forth above are subject to the completion of the company's financial closing procedures. These preliminary estimated financial results have been prepared by, and are the responsibility of, the company's management. The company's independent registered public accounting firm, Baker Tilly HMA LLP, has reviewed these preliminary estimated financial results and other data, but did not audit or express an opinion on them.

The company currently expects that its final results of operations and other data will be consistent with the estimates set forth above, but such estimates are preliminary, and the company's actual results of operations and other data could differ materially from these estimates due to the completion of its financial closing procedures, final adjustments and other developments that may arise between now and the time such consolidated financial statements for the period ended March 31, 2021, are issued.

2021 first quarter results conference call

Delta 9 will release the results for the first quarter of 2021 on May 17, 2021, before the market opens. A conference call to discuss the above results is scheduled for May 17, 2021, premarket. The conference call will be hosted that day at 9 a.m. Eastern Time by Mr. Arbuthnot, chief executive officer, and Jim Lawson, chief financial officer, followed by a question-and-answer period.

Date:  May 17, 2021

Time:  9 a.m. ET

Dial-in number:  1-888-886-7786

Replay (available until midnight ET, Aug. 17, 2021):  1-877-674-6060

Replay passcode:  586812 followed by the number sign

About Delta 9 Cannabis Inc.

Delta 9 Cannabis is a vertically integrated cannabis company focused on bringing the highest-quality cannabis products to market. The company sells cannabis products through its wholesale and retail sales channels, and sells its cannabis grow pods to other businesses. Delta 9's wholly owned subsidiary, Delta 9 Bio-Tech Inc., is a licensed producer of medical and recreational cannabis, and operates an 80,000-square-foot production facility in Winnipeg, Man., Canada. Delta 9 owns and operates a chain of retail stores under the Delta 9 Cannabis Store brand. Delta 9's shares trade on the Toronto Stock Exchange under the symbol DN and on the OTCQX under the symbol DLTNF.

We seek Safe Harbor.

© 2021 Canjex Publishing Ltd. All rights reserved.